Por: K M Diaz, P Veerabhadrappa, M A Kashem4, S R Thakkar, D L Feairheller, K M Sturgeon6, C Ling, S T Williamson, J Kretzschmar, H Lee, H Grimm, D M Babbitt, C Vin, X Fan, D L Crabbe y M D Brown. Journal of Human Hypertension (2013) 27, 671–677.
The purpose of this study was to investigate the association of visit-to-visit and 24-h blood pressure (BP) variability with markers of endothelial injury and vascular function. We recruited 72 African Americans who were non-diabetic, non-smoking and free of cardiovascular (CV) and renal disease. In conclusion, our findings showed that visit-to-visit and 24-h BPV were associated with measures of endothelial injury, endothelial function, and smooth muscle function. These early preliminary results may suggest that high BPV could influence the pathogenesis of CV disease, in part, through influences on vascular health. Additional research, however, will be needed to confirm these results, determine the clinical relevance of the FMD/NMD ratio, and resolve the conflicting hypotheses regarding the interpretation of circulating EMP levels.
Por: N C Barengo, R Antikainen, M Kastarinen, T Laatikainen y J Tuomilehto. Journal of Human Hypertension (2013) 27, 693–697.
he objective of this study (follow-up of 26 113 people) was to investigate differences in the risk of cardiovascular disease (CVD) and all-cause mortality among hypertensive people according to the control of systolic blood pressure (SBP) and diastolic blood pressure (DBP). People with a history of coronary heart disease, heart failure, cancer or incomplete data at baseline (n=1113) were excluded from the study. The participants were classified into six groups according to their blood pressure status. In conclusion, our results strengthen the evidence that uncontrolled SBP alone and uncontrolled DBP alone are risk factors of all-cause and CVD mortality.
En esta sección les exponemos algunos artículos publicados sobre la hipertensión arterial.
De la Revista: American Journal of Hypertension (Sobre la sal)
Por: Theodore A. Kotchen. Am J Hypertens (2013) 26 (10), 1177.
Sodium Reduction Is a Public Health Priority: Reflections on the Institute of Medicine’s Report, Sodium Intake in Populations: Assessment of Evidence
http://ajh.oxfordjournals.org/content/26/10/1178.full
Por: Janelle P. Gunn, Jessica L. Barron, Barbara A. Bowman, Robert K. Merritt, Mary E. Cogswell, Sonia Y. Angell, Ursula E. Bauer y Thomas R. Frieden. Am J Hypertens (2013) 26 (10): 1178-1180.
Getting the Message Right: Reducing Sodium Intake Saves Lives
Por: Jenifer E. Clapp, Christine J. Curtis, Susan M. Kansagra y Thomas A. Farley. Am J Hypertens (2013) 26 (10): 1181-1182.
Extreme Sodium Reductions for the Entire Population: Zealotry or Evidence Based?
Por: Andrew Mente, Martin J. O’Donnell y Salim Yusuf. Am J Hypertens (2013) 26 (10): 1187-1190.
Por: Lawrence J. Appel y Paul K. Whelton. Am J Hypertens (2013) 26 (10): 1183-1186.
Sodium: How and How Not to Set a Nutrient Intake Recommendation
Por: Robert P. Heaney. Am J Hypertens (2013) 26 (10): 1194-1197.
Cost-Effectiveness of Renin-Guided Treatment of Hypertension
Por: Steven M. Smith y Jonathan D. Campbell. American Journal of Hypertension, volume 26, Issue 11, pp. 1303-1310.
A plasma renin activity (PRA)–guided strategy is more effective than standard care in treating hypertension (HTN). However, its clinical implementation has been slow, presumably due in part to economic concerns. We estimated the cost effectiveness of a PRA-guided treatment strategy compared with standard care in a treated but uncontrolled HTN population. Our results suggest that PRA-guided therapy compared with standard care increases QALYs and medical costs in most scenarios. PRA-guided therapy appears to be most cost effective in younger persons and those with more cardiovascular risk factors.
En esta sección les exponemos algunos artículos publicados sobre la hipertensión arterial.
De la Revista: American Journal of Hypertension
Por: Diana Chin, Allegra Battistoni, Giuliano Tocci, Jasmine Passerini, Gianfranco Parati y Massimo Volpe. Am J Hypertens (2012) 25 (12): 1226-1235.
Por: Gabriel Coll-de-Tuero, Marc Saez, Carmen Roca-Saumell, Antonio Rodriguez-Poncelas, Pilar Franco, Antoni Dalfó, Laia Calvó-Perxas, Antonio Pose-Reino y Joan Bayó-Llibre. Am J Hypertens (2012) 25 (12): 1256-1263.
Abdominal Obesity, Body Mass Index, and Hypertension in US Adults: NHANES 2007–2010
Por: Yechiam Ostchega, Jeffery P. Hughes, Ana Terry, Tala H.I. Fakhouri y Ivey Miller. Am J Hypertens (2012) 25 (12): 1271-1278.
Por: Cécilia Cacciolati, Christophe Tzourio, Carole Dufouil, Annick Alpérovitch y Olivier Hanon. Am J Hypertens (2012) 25 (12): 1279-1285.
Comentarios recientes